MedTrace Logo

Hemidiaphragmatic Paralysis With Diluted Continuous Interscalene Plexus Infusions

NCT03592056 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2020-01-23

No results posted yet for this study

Summary

Interscalene brachial plexus block (ISB) constitutes the analgesic criterion standard for shoulder surgery. However, it is associated with a high incidence of hemidiaphragmatic paralysis (HDP) that may not be tolerated by patients with chronic pulmonary disease. Continuous ISBs have not avoided this complication with the reported and regularly used local anesthetic dilutions (i.e. 0.125% bupivacaine, 0.25% ropivacaine, etc). This observational study will register the incidence of HDP in continuous interscalene block (CISB) using a very diluted solution of levobupivacaine (0.04%) in patients undergoing arthroscopic shoulder surgery.

The main objective of this study is to determine the frequency of HDP the first postoperative day before patient discharge(POD).

Conditions

  • Diaphragmatic Paralysis
  • Postoperative Pain
  • Acute Pain
  • Shoulder Pain
  • Shoulder Injury

Sponsors & Collaborators

  • Clinica las Condes, Chile

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-10
Primary Completion
2019-07-23
Completion
2019-07-23

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03592056 on ClinicalTrials.gov